FNY Investment Advisers »

Rxsight shares owned by FNY Investment Advisers

Quarter-by-quarter ownership of Rxsight (RXST) shares owned by FNY Investment Advisers from 13F filings

Historical chart of FNY Investment Advisers investment in Rxsight

Tip: Access up to 7 years of quarterly data

All positions including Rxsight held by FNY Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rxsight by FNY Investment Advisers

Quarter filed Position value Share count Share price at filing
2023-06-30 $126k 4.4k 28.64

More positions owned by FNY Investment Advisers

Cidara Therapeutics (CDTX)
Bank Of Montreal Cadcom (BMO)
Amplify Etf Tr (SILJ)
UnitedHealth (UNH)
Global X Fds global x copper (COPX)
Monolithic Power Systems (MPWR)
Morgan Stanley (MS)
Codere Online Luxembourg Ord (CDRO)
NVIDIA Corporation (NVDA)
Vaneck Vectors Gold Miners mutual (GDX)
Philip Morris International (PM)
Bleichroeder Acquisition Cor (BACQ)
Deere & Company (DE)
Futurecrest Acquisition Corp
Norfolk Southern (NSC)

View all positions for FNY Investment Advisers

Top funds holding Rxsight

BlackRock
Vanguard Group
Millennium Management
D. E. Shaw & Co
Artisan Partners Limited Partnership
No Street GP
Citadel Advisors
Deutsche Bank Aktiengesellschaft
Bnp Paribas Arbitrage, Snc
State Street Corporation
Brown Capital Management
Geode Capital Management
Two Sigma Advisers
Baillie Gifford & Co
Two Sigma Investments

View all funds holding Rxsight